Leukemogenic effect of chemotherapy in patients with breast carcinoma: is it a real concern?
Ibrahim
Nuhad K
NK
D018943:Anthracyclines / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000009:adverse effects; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000209:etiology*
D018943:Anthracyclines; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide